+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Reglan"

Gastroparesis - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Gastroparesis - Market Insight, Epidemiology and Market Forecast - 2034

  • Drug Pipelines
  • February 2024
  • 144 Pages
  • Global
From
From
From
  • 4 Results (Page 1 of 1)
Loading Indicator

Reglan (metoclopramide) is a gastrointestinal drug used to treat symptoms of gastroesophageal reflux disease (GERD) and gastroparesis. It is a dopamine antagonist that works by blocking the action of dopamine in the brain, which helps to reduce nausea and vomiting. It is also used to treat symptoms of irritable bowel syndrome (IBS) and to prevent nausea and vomiting caused by chemotherapy. Reglan is available in both oral and injectable forms. Reglan is a widely used drug in the gastrointestinal market, with a variety of applications. It is used to treat a range of gastrointestinal conditions, including GERD, gastroparesis, and IBS. It is also used to prevent nausea and vomiting caused by chemotherapy. Reglan is available in both oral and injectable forms, making it a versatile treatment option. Companies in the Reglan market include Pfizer, Novartis, Merck, and Sanofi. Show Less Read more